Palbociclib

Pharm Company: * SUN PHARM INDS LTD
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Palbociclib Overview

Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.[1][2] Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.[3] Contents 1 Mechanism of action 2 Administration 3 Approvals and indications 3.1 HR+ breast cancer 4 Adverse effects 5 ...

Read more Palbociclib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Palbociclib

Recent Palbociclib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Palbociclib
  • Capsule: 100mg, 125mg, 75mg
  • Tablet: 100mg, 125mg, 75mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Palbociclib or a similar ingredient: (1 result)